Bioharvest Sciences Inc
CNSX:BHSC
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
P/OCF
Price to Operating Cash Flow (P/OCF) ratio compares a company`s market value to the cash it generates from its core operations.
Price to Operating Cash Flow (P/OCF) ratio compares a company`s market value to the cash it generates from its core operations.
Valuation Scenarios
If P/OCF returns to its Industry Average (6.4), the stock would be worth CA$-3.17 (140% downside from current price).
| Scenario | P/OCF Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | -16.1 | CA$7.95 |
0%
|
| Industry Average | 6.4 | CA$-3.17 |
-140%
|
| Country Average | 10.9 | CA$-5.42 |
-168%
|
Forward P/OCF
Today’s price vs future operating cash flow
Peer Comparison
| Market Cap | P/OCF | P/E | ||||
|---|---|---|---|---|---|---|
| CA |
B
|
Bioharvest Sciences Inc
CNSX:BHSC
|
160.4m CAD | -16.1 | -6.8 | |
| US |
G
|
GE Vernova LLC
NYSE:GEV
|
301B USD | 0 | 0 | |
| UK |
E
|
Eight Capital Partners PLC
F:ECS
|
158.4B EUR | 0 | 0 | |
| US |
C
|
China Industrial Group Inc
OTC:CIND
|
121B USD | 45 422.5 | 4 020.7 | |
| NL |
N
|
Nepi Rockcastle NV
JSE:NRP
|
101.6B ZAR | 11.4 | 10.5 | |
| US |
F
|
Fintech Ecosystem Development Corp
NASDAQ:FEXD
|
67.7B USD | -45 737.4 | 38 243.7 | |
| US |
C
|
CoreWeave Inc
NASDAQ:CRWV
|
56.3B USD | 0 | 0 | |
| CH |
G
|
Galderma Group AG
SIX:GALD
|
38.3B CHF | 0 | 0 | |
| US |
|
Coupang Inc
F:788
|
31.5B EUR | 20.5 | 174.8 | |
| US |
|
Symbotic Inc
NASDAQ:SYM
|
35.8B USD | 39.9 | -3 138.6 | |
| US |
R
|
Reddit Inc
NYSE:RDDT
|
30.6B USD | 41.3 | 53.9 |
Market Distribution
| Min | 0.1 |
| 30th Percentile | 7.2 |
| Median | 10.9 |
| 70th Percentile | 17 |
| Max | 26 053.9 |
Other Multiples
Bioharvest Sciences Inc
Glance View
BioHarvest Sciences, Inc. develops bio farming technology. The company is headquartered in Vancouver, British Columbia. The company went IPO on 2015-08-05. The firm operates through two segments: Superfruits and Cannabis. The Superfruits segment is engaged in the development, design, manufacture and marketing of VINIA for the retail market. The Cannabis segment is focused on the development, design, manufacture and marketing of medical cannabis. Its nutraceutical superfruits product, VINIA, is made of red grape (Vitis vinifera) cells grown in the Company's bioreactor facility. The firm is also engaged in research and development of its BioFarming technology for use in the cannabis industry. This plant-based technology produces cannabis cells. The firm is engaged in the sales of VINIA in the Israeli and United States markets. Its subsidiaries include BioHarvest Inc., Dolarin Ltd. (Dolarin) and Superfood Nutraceuticals Inc. (Superfood).
